125 related articles for article (PubMed ID: 1708985)
21. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with anticancer agents and OK-432.
Kimura I; Onoshi T; Takano J; Osawa H; Yasuhara S
Acta Med Okayama; 1974 Dec; 28(6):411-21. PubMed ID: 4142360
[No Abstract] [Full Text] [Related]
23. [Bleomycin combined with mitomycin C in recurrent cervix cancer].
Tropé C; Simonsen E; Johnsson JE; Sigurdsson K
Lakartidningen; 1982 Apr; 79(17):1689-91. PubMed ID: 6178913
[No Abstract] [Full Text] [Related]
24. Antitumor activity of antibiotic G-253.
Hata T; Nomura S; Umesawa I
Antimicrob Agents Chemother (Bethesda); 1966; 6():543-5. PubMed ID: 5985286
[No Abstract] [Full Text] [Related]
25. [Chemotherapy of tumors. 3. Chemical review of natural antineoplastic agents: antibiotics and related compounds; enzymes and hormones].
Artico M
Farmaco Sci; 1974 Aug; 29(8):598-646. PubMed ID: 4136312
[No Abstract] [Full Text] [Related]
26. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
27. Effects of bleomycin on human and experimental squamous carcinoma.
Michaels L; Grey PA; Rowson KE
J Pathol; 1972 Jan; 106(1):Pxi. PubMed ID: 4113823
[No Abstract] [Full Text] [Related]
28. Cancer: the rules of attraction.
Neckers L; Lee YS
Nature; 2003 Sep; 425(6956):357-9. PubMed ID: 14508471
[No Abstract] [Full Text] [Related]
29. Combination cancer therapy: Presidential address.
Frei E
Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
[No Abstract] [Full Text] [Related]
30. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
[TBL] [Abstract][Full Text] [Related]
31. Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin-6 in nude mice.
Moriyama K; Williams PJ; Niewolna M; Dallas MR; Uehara Y; Mundy GR; Yoneda T
J Bone Miner Res; 1996 Jul; 11(7):905-11. PubMed ID: 8797110
[TBL] [Abstract][Full Text] [Related]
32. Geldanamycin analogs.
Sausville EA
J Chemother; 2004 Nov; 16 Suppl 4():68-9. PubMed ID: 15688614
[TBL] [Abstract][Full Text] [Related]
33. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.
Beliakoff J; Bagatell R; Paine-Murrieta G; Taylor CW; Lykkesfeldt AE; Whitesell L
Clin Cancer Res; 2003 Oct; 9(13):4961-71. PubMed ID: 14581371
[TBL] [Abstract][Full Text] [Related]
34. Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy.
Kimura I; Onoshi T; Yasuhara S; Watanabe T; Sugiyama M; Hiraki K
Acta Med Okayama; 1974 Dec; 28(6):423-31. PubMed ID: 4142361
[No Abstract] [Full Text] [Related]
35. [Antineoplastic activity of a new antibiotic agent carminomycin].
Shorin VA; Bazhanov VS; Averbuch LA; Lepeshkina GN; Grinshteĭn AM
Antibiotiki; 1973 Aug; 18(8):681-6. PubMed ID: 4521406
[No Abstract] [Full Text] [Related]
36. Effects of bleomycin on human and experimental squamous carcinoma.
Michaels L; Grey PA; Rowson KE
J Pathol; 1973 Apr; 109(4):315-21. PubMed ID: 4124412
[No Abstract] [Full Text] [Related]
37. Mitomycins.
Verweij J
Cancer Chemother Biol Response Modif; 1996; 16():48-56. PubMed ID: 8639396
[No Abstract] [Full Text] [Related]
38. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
[TBL] [Abstract][Full Text] [Related]
39. [Low-molecular-weight immunocorrectors of natural origin].
Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
[No Abstract] [Full Text] [Related]
40. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs.
Blagosklonny MV
Leukemia; 2002 Apr; 16(4):455-62. PubMed ID: 11960322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
